Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.594, 2010-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Exenatide trumps insulin glargine in cost effectiveness
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 586, 2009-01 ,pp. :
Access to resources
Recommend
By Gillies P.S. Figgitt D.P. Lamb H.M.
Drugs, Vol. 59, Iss. 2, 2000-02 ,pp. :
Insulin glargine better value than NPH in T2DM
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
Insulin glargine better value than NPH in T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. :
Inpatient costs lower with torasemide than furosemide
Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. :